Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.280
-0.070 (-5.19%)
At close: Aug 24, 2026, 4:00 PM EDT
1.320
+0.040 (3.13%)
Pre-market: Aug 25, 2026, 4:30 AM EDT

PACB Revenue

Pacific Biosciences of California had revenue of $39.01M in the quarter ending June 30, 2026, a decrease of -1.91%. This brings the company's revenue in the last twelve months to $159.27M, up 2.02% year-over-year. In the year 2025, Pacific Biosciences of California had annual revenue of $160.01M with 3.89% growth.

Revenue (ttm)
$159.27M
Revenue Growth
+2.02%
P/S Ratio
2.50
Revenue / Employee
$328,394
Employees
485
Market Cap
397.86M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025160.01M5.99M3.89%
Dec 31, 2024154.01M-46.51M-23.19%
Dec 31, 2023200.52M72.22M56.29%
Dec 31, 2022128.30M-2.21M-1.69%
Dec 31, 2021130.51M51.62M65.43%
Dec 31, 202078.89M-12.00M-13.20%
Dec 31, 201990.89M12.27M15.60%
Dec 31, 201878.63M-14.84M-15.88%
Dec 31, 201793.47M2.75M3.04%
Dec 31, 201690.71M-2.07M-2.23%
Dec 31, 201592.78M32.19M53.12%
Dec 31, 201460.59M32.41M115.02%
Dec 31, 201328.18M2.20M8.46%
Dec 31, 201225.98M-7.88M-23.27%
Dec 31, 201133.86M32.19M1,922.88%
Dec 31, 20101.67M1.54M1,140.00%
Dec 31, 2009135.00K-766.00K-85.02%
Dec 31, 2008901.00K-1.26M-58.34%
Dec 31, 20072.16M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.